Kovács Árpád, Fülöp Gábor Á, Kovács Andrea, Csípő Tamás, Bódi Beáta, Priksz Dániel, Juhász Béla, Beke Lívia, Hendrik Zoltán, Méhes Gábor, Granzier Henk L, Édes István, Fagyas Miklós, Papp Zoltán, Barta Judit, Tóth Attila
Division of Clinical Physiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary;
Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, University of Debrecen, Debrecen, Hungary;
Am J Physiol Heart Circ Physiol. 2016 Jun 1;310(11):H1671-82. doi: 10.1152/ajpheart.00842.2015. Epub 2016 Apr 8.
Hypertension (HTN) is a major risk factor for heart failure. We investigated the influence of HTN on cardiac contraction and relaxation in transgenic renin overexpressing rats (carrying mouse Ren-2 renin gene, mRen2, n = 6). Blood pressure (BP) was measured. Cardiac contractility was characterized by echocardiography, cellular force measurements, and biochemical assays were applied to reveal molecular mechanisms. Sprague-Dawley (SD) rats (n = 6) were used as controls. Transgenic rats had higher circulating renin activity and lower cardiac angiotensin-converting enzyme two levels. Systolic BP was elevated in mRen2 rats (235.11 ± 5.32 vs. 127.03 ± 7.56 mmHg in SD, P < 0.05), resulting in increased left ventricular (LV) weight/body weight ratio (4.05 ± 0.09 vs. 2.77 ± 0.08 mg/g in SD, P < 0.05). Transgenic renin expression had no effect on the systolic parameters, such as LV ejection fraction, cardiomyocyte Ca(2+)-activated force, and Ca(2+) sensitivity of force production. In contrast, diastolic dysfunction was observed in mRen2 compared with SD rats: early and late LV diastolic filling ratio (E/A) was lower (1.14 ± 0.04 vs. 1.87 ± 0.08, P < 0.05), LV isovolumetric relaxation time was longer (43.85 ± 0.89 vs. 28.55 ± 1.33 ms, P < 0.05), cardiomyocyte passive tension was higher (1.74 ± 0.06 vs. 1.28 ± 0.18 kN/m(2), P < 0.05), and lung weight/body weight ratio was increased (6.47 ± 0.24 vs. 5.78 ± 0.19 mg/g, P < 0.05), as was left atrial weight/body weight ratio (0.21 ± 0.03 vs. 0.14 ± 0.03 mg/g, P < 0.05). Hyperphosphorylation of titin at Ser-12742 within the PEVK domain and a twofold overexpression of protein kinase C-α in mRen2 rats were detected. Our data suggest a link between the activation of renin-angiotensin-aldosterone system and increased titin-based stiffness through phosphorylation of titin's PEVK element, contributing to diastolic dysfunction.
高血压(HTN)是心力衰竭的主要危险因素。我们研究了高血压对转基因肾素过表达大鼠(携带小鼠Ren-2肾素基因,mRen2,n = 6)心脏收缩和舒张的影响。测量了血压(BP)。通过超声心动图对心脏收缩性进行了表征,采用细胞力测量法,并应用生化分析来揭示分子机制。将斯普拉格-道利(SD)大鼠(n = 6)用作对照。转基因大鼠具有更高的循环肾素活性和更低的心脏血管紧张素转换酶2水平。mRen2大鼠的收缩压升高(235.11±5.32 mmHg,而SD大鼠为127.03±7.56 mmHg,P < 0.05),导致左心室(LV)重量/体重比增加(4.05±0.09 vs. SD大鼠的2.77±0.08 mg/g,P < 0.05)。转基因肾素表达对收缩参数没有影响,如左心室射血分数、心肌细胞Ca(2+)激活的力以及力产生的Ca(2+)敏感性。相比之下,与SD大鼠相比,在mRen2大鼠中观察到舒张功能障碍:左心室舒张早期和晚期充盈率(E/A)较低(1.14±0.04 vs. 1.87±0.08,P < 0.05),左心室等容舒张时间更长(43.85±0.89 vs. 28.55±1.33 ms,P < 0.05),心肌细胞被动张力更高(1.74±0.06 vs. 1.28±0.18 kN/m(2),P < 0.05),肺重量/体重比增加(6.47±0.24 vs. 5.78±0.19 mg/g,P < 0.05),左心房重量/体重比也增加(0.21±0.03 vs. 0.14±0.03 mg/g,P < 0.05)。在mRen2大鼠中检测到肌联蛋白在PEVK结构域内的Ser-12742位点发生过度磷酸化以及蛋白激酶C-α的表达增加了两倍。我们的数据表明肾素-血管紧张素-醛固酮系统的激活与通过肌联蛋白的PEVK元件磷酸化导致的基于肌联蛋白的僵硬度增加之间存在联系,这导致了舒张功能障碍。